Blog
-
-
ASCO: AstraZeneca’s Tagrisso, headed for big sales boost, cuts lung cancer recurrence by 83%
-
Higher dose of CAR T cells may be more effective in advanced chronic lymphocytic leukemia
-
ASCO: J&J’s Erleada extends lives by 14 months in nonmetastatic prostate cancer
-
The medications that are thrown away
-
Medtronic continuous dialysis system designed for small children gets FDA nod
-
Insurers deny 25% of medication claims for infant respiratory illness
-
Deep learning–MRI classification combo called a ‘great leap forward’ in glioma care
-
Early treatment with Novartis’ Mayzent stalls secondary progressive MS: study
-
Bristol Myers, Exelixis scored a kidney cancer combo win. But is there room for their duo on the market?